Literature DB >> 31257021

Editorial overview: Peptides in cancer.

Jonathan Whitfield1, Laura Soucek2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31257021      PMCID： PMC6768800          DOI： 10.1016/j.coph.2019.06.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


× No keyword cloud information.
  10 in total

Review 1.  The future of peptides in cancer treatment.

Authors:  Kaido Kurrikoff; David Aphkhazava; Ülo Langel
Journal:  Curr Opin Pharmacol       Date:  2019-03-08       Impact factor: 5.547

Review 2.  Peptides as cancer vaccines.

Authors:  Marta Calvo Tardón; Mathilde Allard; Valérie Dutoit; Pierre-Yves Dietrich; Paul R Walker
Journal:  Curr Opin Pharmacol       Date:  2019-03-01       Impact factor: 5.547

Review 3.  Therapeutic peptides: Historical perspectives, current development trends, and future directions.

Authors:  Jolene L Lau; Michael K Dunn
Journal:  Bioorg Med Chem       Date:  2017-07-01       Impact factor: 3.641

Review 4.  Recent advances of anti-cancer therapies including the use of cell-penetrating peptides.

Authors:  Annika Klimpel; Tamara Lützenburg; Ines Neundorf
Journal:  Curr Opin Pharmacol       Date:  2019-02-13       Impact factor: 5.547

Review 5.  Tumor targeting peptides: novel therapeutic strategies in glioblastoma.

Authors:  Drazen Raucher
Journal:  Curr Opin Pharmacol       Date:  2019-02-15       Impact factor: 5.547

Review 6.  Peptides in clinical development for the treatment of brain tumors.

Authors:  Giulia Guidotti; Liliana Brambilla; Daniela Rossi
Journal:  Curr Opin Pharmacol       Date:  2019-04-05       Impact factor: 5.547

Review 7.  Drugging the 'undruggable' cancer targets.

Authors:  Chi V Dang; E Premkumar Reddy; Kevan M Shokat; Laura Soucek
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

Review 8.  Protein-driven nanomedicines in oncotherapy.

Authors:  Isolda Casanova; Ugutz Unzueta; Irene Arroyo-Solera; Maria Virtudes Céspedes; Antonio Villaverde; Ramon Mangues; Esther Vazquez
Journal:  Curr Opin Pharmacol       Date:  2019-01-25       Impact factor: 5.547

9.  Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.

Authors:  Marie-Eve Beaulieu; Toni Jauset; Daniel Massó-Vallés; Sandra Martínez-Martín; Peter Rahl; Loïka Maltais; Mariano F Zacarias-Fluck; Sílvia Casacuberta-Serra; Erika Serrano Del Pozo; Christopher Fiore; Laia Foradada; Virginia Castillo Cano; Meritxell Sánchez-Hervás; Matthew Guenther; Eduardo Romero Sanz; Marta Oteo; Cynthia Tremblay; Génesis Martín; Danny Letourneau; Martin Montagne; Miguel Ángel Morcillo Alonso; Jonathan R Whitfield; Pierre Lavigne; Laura Soucek
Journal:  Sci Transl Med       Date:  2019-03-20       Impact factor: 17.956

Review 10.  Strategies to Inhibit Myc and Their Clinical Applicability.

Authors:  Jonathan R Whitfield; Marie-Eve Beaulieu; Laura Soucek
Journal:  Front Cell Dev Biol       Date:  2017-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.